RA
BMY icon

Reby Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Reby Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$124K Buy
+1,996
New +$123K 0.03% 124

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Reby Advisors's BMY Position: Q4 2020 in Review

Reby Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q4 2020: 1,996 shares worth $124K. The stake represents 0.03% of the portfolio and ranks #124 among its holdings.

2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Reby Advisors held 1,996 shares of Bristol-Myers Squibb worth $124K as of Q4 2020.
  • Bristol-Myers Squibb was a new Reby Advisors position in Q4 2020.
  • Bristol-Myers Squibb made up 0.03% of Reby Advisors's portfolio in Q4 2020, its #124 holding.
  • 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Reby Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.